DGX logo

QUEST DIAGNOSTICS INC

DGXNYSE
πŸ† #437 by market capEarnings Feb 8 Β· PostUS Equity
β€”β€”
Quote unavailable
πŸ””
Track DGX
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$26.82B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
9.1%
Slowing
πŸ“ŠGross Margin
33.2%
Moderate
πŸ’΅FCF Margin
11.6%
Healthy
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
80
Strong
No chart data available for DGX.

Trading Snapshot

Day Range
β€”
52-Week Range
$171.18 – $248.84
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
110.0M
Next Earnings
2027-02-08

Fundamentals Snapshot

Annual Revenue
$11.04B
Last Q Revenue
$3.10B
P/E Ratio
23.8
P/S Ratio
2.3x
EPS (TTM)
$10.06
Dividend Yield
1.37%
Dilution (1yr)
βˆ’0.9%
DGX logo

QUEST DIAGNOSTICS INC

DGX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$11.0Bβ–² +11.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
31.9%β–Ό βˆ’2.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.6Bβ–² +19.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.4Bβ–² +49.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
112.0Mβ–Ό βˆ’0.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$6.5Bβ–Ό βˆ’$123M YoY
StockOtter Β· stockotter.space

About QUEST DIAGNOSTICS INC

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
80/100
Analyst data unavailable.

Latest News & Updates

News unavailable.